chr14-50247074-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000267436.9(L2HGDH):āc.1376A>Gā(p.Gln459Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,613,540 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
ENST00000267436.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
L2HGDH | NM_024884.3 | c.1376A>G | p.Gln459Arg | missense_variant | 10/10 | ENST00000267436.9 | NP_079160.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
L2HGDH | ENST00000267436.9 | c.1376A>G | p.Gln459Arg | missense_variant | 10/10 | 1 | NM_024884.3 | ENSP00000267436 | P1 | |
L2HGDH | ENST00000261699.8 | c.1197-9349A>G | intron_variant | 1 | ENSP00000261699 | |||||
L2HGDH | ENST00000421284.7 | c.1376A>G | p.Gln459Arg | missense_variant | 10/11 | 2 | ENSP00000405559 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152222Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251084Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135724
GnomAD4 exome AF: 0.000112 AC: 163AN: 1461318Hom.: 0 Cov.: 32 AF XY: 0.000116 AC XY: 84AN XY: 726902
GnomAD4 genome AF: 0.000131 AC: 20AN: 152222Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74374
ClinVar
Submissions by phenotype
L-2-hydroxyglutaric aciduria Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 07, 2022 | This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 459 of the L2HGDH protein (p.Gln459Arg). This variant is present in population databases (rs375890787, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with L2HGDH-related conditions. ClinVar contains an entry for this variant (Variation ID: 1032202). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 23, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at